HVC
DRRX

Healthcare Value Capital’s DURECT Corp DRRX Stock Holding History

Healthcare Value Capital’s Portfolio DRRX Stock Details DRRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$320K Buy
+25,000
New +$339K 0.63% 24

Other funds holding DRRX

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare Value Capital's DRRX Position: Q3 2021 in Review

Healthcare Value Capital opened a new position in DURECT Corp (DRRX) in Q3 2021: 25,000 shares worth $320K. The stake represents 0.63% of the portfolio and ranks #24 among its holdings.

110 funds tracked by Wall St. Rank hold DRRX as of Q3 2021.

  • Healthcare Value Capital held 25,000 shares of DURECT Corp worth $320K as of Q3 2021.
  • DURECT Corp was a new Healthcare Value Capital position in Q3 2021.
  • DURECT Corp made up 0.63% of Healthcare Value Capital's portfolio in Q3 2021, its #24 holding.
  • 110 funds tracked by Wall St. Rank held DURECT Corp as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.